% | $
Quotes you view appear here for quick access.

Sucampo Pharmaceuticals, Inc. Message Board

  • biotech_chairman_and_ceo biotech_chairman_and_ceo Feb 27, 2014 7:52 AM Flag

    The only surprise is they brought in a new CEO. I thought for sure the company would be acquired for $600 million



    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • What the hell you are talking about. The price of the company is over $1.5 billion. You cannot find any small medical company with so many promising pipe line and 2 important approved drugs.
      CEO change was a good strategy that benefit the company, CEO and all shareholders.

      Sentiment: Strong Buy

    • It is a possibility not to be ruled out yet. However, with partnerships already established an outright sale would be a bit more complicated wouldn't it?
      I am predicting a more steady rise to $14 or higher towards end of the year as folks realize the potential. There are a few driving forces that are important.
      1) As martin pointed out the CEO comp increase linked to $16 stock price
      2) with Yueno still holding 20Million of scmp stock he would definitely want to retire with this valued over $16.
      3) Yeno is focussed on earning dividends for the huge volume of scmp he holds.
      4) ofcourse the pipeline (spinal stenosis, amitiza in europe etc).

      Sentiment: Strong Buy

10.71-0.24(-2.19%)Jun 24 4:00 PMEDT